$ISTA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ISTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ISTA PHARMACEUTICALS INC. Get notifications about new insider transactions in ISTA PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Buy | P | 1.00 | 14,900 | 14,900 | 38,450 | 23.6 K to 38.5 K (+63.27 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 0.84 | 7,550 | 6,353 | 253,266 | 245.7 K to 253.3 K (+3.07 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 0.79 | 11,100 | 8,769 | 11,100 | |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Grant | A | 0.00 | 2,466 | 2 | 67,532 | 65.1 K to 67.5 K (+3.79 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | LAPORTE KATHLEEN | Director | Option Exercise | A | 0.79 | 11,100 | 8,769 | 11,100 | |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | LAPORTE KATHLEEN | Director | Grant | A | 0.00 | 2,466 | 2 | 7,932 | 5.5 K to 7.9 K (+45.12 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | HUTT PETER BARTON | Director | Option Exercise | A | 0.79 | 11,100 | 8,769 | 11,100 | |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | HUTT PETER BARTON | Director | Grant | A | 0.00 | 2,466 | 2 | 4,932 | 2.5 K to 4.9 K (+100.00 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MITCHELL DEAN J | Director | Option Exercise | A | 0.79 | 11,100 | 8,769 | 11,100 | |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 2,466 | 2 | 4,932 | 2.5 K to 4.9 K (+100.00 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MCGRAW BENJAMIN F III | Director | Option Exercise | A | 0.79 | 11,100 | 8,769 | 11,100 | |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MCGRAW BENJAMIN F III | Director | Grant | A | 0.00 | 2,466 | 2 | 7,932 | 5.5 K to 7.9 K (+45.12 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | PERLMAN ANDREW J | Director | Option Exercise | A | 0.79 | 11,100 | 8,769 | 11,100 | |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | PERLMAN ANDREW J | Director | Grant | A | 0.00 | 2,466 | 2 | 4,932 | 2.5 K to 4.9 K (+100.00 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ROE WAYNE I | Director | Option Exercise | A | 0.79 | 11,100 | 8,769 | 11,100 | |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ROE WAYNE I | Director | Grant | A | 0.00 | 2,466 | 2 | 7,932 | 5.5 K to 7.9 K (+45.12 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Buy | P | 0.98 | 30,000 | 29,343 | 108,641 | 78.6 K to 108.6 K (+38.15 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Buy | P | 0.77 | 3,575 | 2,743 | 78,641 | 75.1 K to 78.6 K (+4.76 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Buy | P | 0.79 | 10,000 | 7,937 | 75,066 | 65.1 K to 75.1 K (+15.37 %) |
Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 0.99 | 83,000 | 82,253 | 245,716 | 162.7 K to 245.7 K (+51.01 %) |
Dec 11 2008 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Buy | P | 0.73 | 34,600 | 25,365 | 65,066 | 30.5 K to 65.1 K (+113.57 %) |
Dec 11 2008 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Buy | P | 0.76 | 13,300 | 10,167 | 31,750 | 18.5 K to 31.8 K (+72.09 %) |
Dec 11 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 0.75 | 8,000 | 6,000 | 162,716 | 154.7 K to 162.7 K (+5.17 %) |
Dec 11 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 0.66 | 22,712 | 14,954 | 154,716 | 132 K to 154.7 K (+17.21 %) |
Dec 11 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 0.67 | 67,100 | 45,252 | 132,004 | 64.9 K to 132 K (+103.38 %) |
Dec 11 2008 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Buy | P | 0.63 | 5,649 | 3,566 | 22,769 | 17.1 K to 22.8 K (+33.00 %) |
Dec 11 2008 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Buy | P | 0.63 | 17,000 | 10,698 | 43,353 | 26.4 K to 43.4 K (+64.51 %) |
Mar 05 2008 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Sell | D | 5.45 | 178 | 970 | 9,322 | 9.5 K to 9.3 K (-1.87 %) |
Feb 20 2008 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Payment of Exercise | F | 4.56 | 223 | 1,017 | 16,690 | 16.9 K to 16.7 K (-1.32 %) |
Feb 20 2008 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Payment of Exercise | F | 4.56 | 375 | 1,710 | 18,450 | 18.8 K to 18.5 K (-1.99 %) |
Feb 20 2008 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Payment of Exercise | F | 4.56 | 348 | 1,587 | 23,550 | 23.9 K to 23.6 K (-1.46 %) |
Feb 20 2008 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Payment of Exercise | F | 4.56 | 545 | 2,485 | 21,263 | 21.8 K to 21.3 K (-2.50 %) |
Feb 20 2008 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Payment of Exercise | F | 4.56 | 384 | 1,751 | 17,120 | 17.5 K to 17.1 K (-2.19 %) |
Feb 20 2008 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Payment of Exercise | F | 4.56 | 500 | 2,280 | 26,269 | 26.8 K to 26.3 K (-1.87 %) |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 4.46 | 26,916 | 120,045 | 26,916 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 4.46 | 11,084 | 49,435 | 11,084 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Grant | A | 0.00 | 8,000 | 8 | 16,913 | 8.9 K to 16.9 K (+89.76 %) |
Feb 20 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Payment of Exercise | F | 4.56 | 1,662 | 7,579 | 65,054 | 66.7 K to 65.1 K (-2.49 %) |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 4.46 | 18,311 | 81,667 | 18,311 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 4.46 | 18,689 | 83,353 | 18,689 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Grant | A | 0.00 | 8,000 | 8 | 18,825 | 10.8 K to 18.8 K (+73.90 %) |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 4.46 | 26,482 | 118,110 | 26,482 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 4.46 | 17,518 | 78,130 | 17,518 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Grant | A | 0.00 | 10,000 | 10 | 21,808 | 11.8 K to 21.8 K (+84.69 %) |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Option Exercise | A | 4.46 | 32,570 | 145,262 | 32,570 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Option Exercise | A | 4.46 | 21,780 | 97,139 | 21,780 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Grant | A | 0.00 | 13,200 | 13 | 23,898 | 10.7 K to 23.9 K (+123.39 %) |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Option Exercise | A | 4.46 | 18,604 | 82,974 | 18,604 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Option Exercise | A | 4.46 | 19,396 | 86,506 | 19,396 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Grant | A | 0.00 | 8,000 | 8 | 17,504 | 9.5 K to 17.5 K (+84.18 %) |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | A | 4.46 | 29,097 | 129,773 | 29,097 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | A | 4.46 | 18,903 | 84,307 | 18,903 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Grant | A | 0.00 | 10,500 | 11 | 26,769 | 16.3 K to 26.8 K (+64.54 %) |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 4.46 | 140,906 | 628,441 | 140,906 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 4.46 | 22,744 | 101,438 | 22,744 | |
Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Grant | A | 0.00 | 36,500 | 37 | 66,716 | 30.2 K to 66.7 K (+120.80 %) |
Feb 05 2008 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Payment of Exercise | F | 5.27 | 587 | 3,093 | 8,913 | 9.5 K to 8.9 K (-6.18 %) |
Feb 05 2008 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Payment of Exercise | F | 5.27 | 747 | 3,937 | 11,808 | 12.6 K to 11.8 K (-5.95 %) |
Feb 05 2008 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Payment of Exercise | F | 5.27 | 854 | 4,501 | 10,698 | 11.6 K to 10.7 K (-7.39 %) |
Feb 05 2008 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Payment of Exercise | F | 5.27 | 673 | 3,547 | 9,504 | 10.2 K to 9.5 K (-6.61 %) |
Feb 05 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Payment of Exercise | F | 5.27 | 2,222 | 11,710 | 30,216 | 32.4 K to 30.2 K (-6.85 %) |
Feb 05 2008 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Payment of Exercise | F | 5.27 | 831 | 4,379 | 16,269 | 17.1 K to 16.3 K (-4.86 %) |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | ROE WAYNE I | Director | Option Exercise | A | 6.90 | 11,100 | 76,590 | 11,100 | |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | ROE WAYNE I | Director | Grant | A | 0.00 | 2,466 | 2 | 5,466 | 3 K to 5.5 K (+82.20 %) |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | ROE WAYNE I | Director | Grant | A | 0.00 | 1,500 | 2 | 3,000 | 1.5 K to 3 K (+100.00 %) |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 6.90 | 11,100 | 76,590 | 11,100 | |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Grant | A | 0.00 | 2,466 | 2 | 30,466 | 28 K to 30.5 K (+8.81 %) |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Grant | A | 0.00 | 1,500 | 2 | 3,000 | 1.5 K to 3 K (+100.00 %) |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | MCGRAW BENJAMIN F III | Director | Option Exercise | A | 6.90 | 11,100 | 76,590 | 11,100 | |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | MCGRAW BENJAMIN F III | Director | Grant | A | 0.00 | 2,466 | 2 | 5,466 | 3 K to 5.5 K (+82.20 %) |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | MCGRAW BENJAMIN F III | Director | Grant | A | 0.00 | 1,500 | 2 | 3,000 | 1.5 K to 3 K (+100.00 %) |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | LAPORTE KATHLEEN | Director | Option Exercise | A | 6.90 | 11,100 | 76,590 | 11,100 | |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | LAPORTE KATHLEEN | Director | Grant | A | 0.00 | 2,466 | 2 | 5,466 | 3 K to 5.5 K (+82.20 %) |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | LAPORTE KATHLEEN | Director | Grant | A | 0.00 | 1,500 | 2 | 3,000 | 1.5 K to 3 K (+100.00 %) |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | HUTT PETER BARTON | Director | Option Exercise | A | 6.90 | 11,100 | 76,590 | 11,100 | |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | HUTT PETER BARTON | Director | Grant | A | 0.00 | 2,466 | 2 | 2,466 | 0 to 2.5 K |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | MITCHELL DEAN J | Director | Option Exercise | A | 6.90 | 11,100 | 76,590 | 11,100 | |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 2,466 | 2 | 2,466 | 0 to 2.5 K |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | PERLMAN ANDREW J | Director | Option Exercise | A | 6.90 | 11,100 | 76,590 | 11,100 | |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | PERLMAN ANDREW J | Director | Option Exercise | A | 5.75 | 20,000 | 115,000 | 20,000 | |
Oct 15 2007 | ISTA | ISTA PHARMACEUTICA ... | PERLMAN ANDREW J | Director | Grant | A | 0.00 | 2,466 | 2 | 2,466 | 0 to 2.5 K |
Oct 01 2007 | ISTA | ISTA PHARMACEUTICA ... | CREDIT SUISSE/ | 10% Owner | Option Exercise | X | 3.80 | 689,473 | 2,619,997 | 0 | |
Oct 01 2007 | ISTA | ISTA PHARMACEUTICA ... | CREDIT SUISSE/ | 10% Owner | Buy | X | 3.80 | 689,473 | 2,619,997 | 7,527,629 | 6.8 M to 7.5 M (+10.08 %) |
Jul 03 2007 | ISTA | ISTA PHARMACEUTICA ... | CREDIT SUISSE/ | 10% Owner | Buy | P | 7.00 | 928,570 | 6,499,990 | 7,518,497 | 6.6 M to 7.5 M (+14.09 %) |
Jun 19 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.10 | 9,528 | 77,184 | 1,860,874 | 1.9 M to 1.9 M (-0.51 %) |
Jun 19 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.10 | 4,083 | 33,076 | 797,518 | 801.6 K to 797.5 K (-0.51 %) |
Jun 19 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.10 | 9,528 | 77,184 | 1,860,874 | 1.9 M to 1.9 M (-0.51 %) |
Jun 04 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.03 | 1,734 | 13,931 | 1,870,402 | 1.9 M to 1.9 M (-0.09 %) |
Jun 04 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.49 | 4,938 | 41,899 | 1,872,136 | 1.9 M to 1.9 M (-0.26 %) |
Jun 04 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.00 | 8,190 | 65,555 | 1,877,074 | 1.9 M to 1.9 M (-0.43 %) |
Jun 04 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.03 | 743 | 5,969 | 801,601 | 802.3 K to 801.6 K (-0.09 %) |
Jun 04 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.49 | 2,116 | 17,954 | 802,344 | 804.5 K to 802.3 K (-0.26 %) |
Jun 04 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.00 | 3,510 | 28,095 | 804,460 | 808 K to 804.5 K (-0.43 %) |
Jun 04 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.03 | 1,734 | 13,931 | 1,870,402 | 1.9 M to 1.9 M (-0.09 %) |
Jun 04 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.49 | 4,938 | 41,899 | 1,872,136 | 1.9 M to 1.9 M (-0.26 %) |
Jun 04 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.00 | 8,190 | 65,555 | 1,877,074 | 1.9 M to 1.9 M (-0.43 %) |
May 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.00 | 7,000 | 56,034 | 1,885,264 | 1.9 M to 1.9 M (-0.37 %) |
May 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 7.52 | 10,500 | 78,940 | 1,892,264 | 1.9 M to 1.9 M (-0.55 %) |
May 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 7.14 | 10,500 | 74,935 | 1,902,764 | 1.9 M to 1.9 M (-0.55 %) |
May 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.00 | 3,000 | 24,015 | 807,970 | 811 K to 808 K (-0.37 %) |
May 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 7.52 | 4,500 | 33,831 | 810,970 | 815.5 K to 811 K (-0.55 %) |
May 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 7.14 | 4,500 | 32,115 | 815,470 | 820 K to 815.5 K (-0.55 %) |
May 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.00 | 7,000 | 56,034 | 1,885,264 | 1.9 M to 1.9 M (-0.37 %) |
May 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 7.52 | 10,500 | 78,940 | 1,892,264 | 1.9 M to 1.9 M (-0.55 %) |
May 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 7.14 | 10,500 | 74,935 | 1,902,764 | 1.9 M to 1.9 M (-0.55 %) |
May 02 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 10.25 | 3,319 | 34,020 | 1,913,264 | 1.9 M to 1.9 M (-0.17 %) |
May 02 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 10.25 | 1,423 | 14,586 | 819,970 | 821.4 K to 820 K (-0.17 %) |
May 02 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 10.25 | 3,319 | 34,020 | 1,913,264 | 1.9 M to 1.9 M (-0.17 %) |
Apr 30 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 10.09 | 13,574 | 136,989 | 821,393 | 835 K to 821.4 K (-1.63 %) |
Apr 30 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 10.00 | 22,090 | 220,995 | 834,967 | 857.1 K to 835 K (-2.58 %) |
Apr 30 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 10.09 | 31,674 | 319,654 | 1,916,583 | 1.9 M to 1.9 M (-1.63 %) |
Apr 30 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 10.00 | 51,542 | 515,642 | 1,948,257 | 2 M to 1.9 M (-2.58 %) |
Apr 30 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 10.09 | 31,674 | 319,654 | 1,916,583 | 1.9 M to 1.9 M (-1.63 %) |
Apr 30 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 10.00 | 51,542 | 515,642 | 1,948,257 | 2 M to 1.9 M (-2.58 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Option Exercise | X | 3.80 | 339,868 | 1,291,498 | 0 | |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Option Exercise | X | 3.80 | 32,237 | 122,501 | 339,868 | |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | J | 8.40 | 153,824 | 1,291,506 | 1,999,799 | 2.2 M to 2 M (-7.14 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Buy | X | 3.80 | 339,868 | 1,291,498 | 2,153,623 | 1.8 M to 2.2 M (+18.74 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | J | 8.40 | 14,591 | 122,506 | 1,813,755 | 1.8 M to 1.8 M (-0.80 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Buy | X | 3.80 | 32,237 | 122,501 | 1,828,346 | 1.8 M to 1.8 M (+1.79 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Option Exercise | X | 3.80 | 145,658 | 553,500 | 0 | |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Option Exercise | X | 3.80 | 13,816 | 52,501 | 145,658 | |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Option Exercise | X | 3.80 | 339,868 | 1,291,498 | 0 | |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Option Exercise | X | 3.80 | 32,237 | 122,501 | 339,868 | |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | J | 8.40 | 65,925 | 553,506 | 857,057 | 923 K to 857.1 K (-7.14 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Buy | X | 3.80 | 145,658 | 553,500 | 922,982 | 777.3 K to 923 K (+18.74 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | J | 8.40 | 6,254 | 52,509 | 777,324 | 783.6 K to 777.3 K (-0.80 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Buy | X | 3.80 | 13,816 | 52,501 | 783,578 | 769.8 K to 783.6 K (+1.79 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | J | 8.40 | 153,824 | 1,291,506 | 1,999,799 | 2.2 M to 2 M (-7.14 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Buy | X | 3.80 | 339,868 | 1,291,498 | 2,153,623 | 1.8 M to 2.2 M (+18.74 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | J | 8.40 | 14,591 | 122,506 | 1,813,755 | 1.8 M to 1.8 M (-0.80 %) |
Apr 12 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Buy | X | 3.80 | 32,237 | 122,501 | 1,828,346 | 1.8 M to 1.8 M (+1.79 %) |
Mar 13 2007 | ISTA | ISTA PHARMACEUTICA ... | CLASSON ROLF A | Director | Option Exercise | M | 5.82 | 16,000 | 93,120 | 0 | |
Mar 13 2007 | ISTA | ISTA PHARMACEUTICA ... | CLASSON ROLF A | Director | Buy | M | 5.82 | 16,000 | 93,120 | 16,000 | 0 to 16 K |
Mar 08 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.80 | 7,500 | 66,005 | 769,762 | 777.3 K to 769.8 K (-0.96 %) |
Mar 08 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.52 | 10,950 | 93,332 | 777,262 | 788.2 K to 777.3 K (-1.39 %) |
Mar 08 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.80 | 17,500 | 154,011 | 1,796,109 | 1.8 M to 1.8 M (-0.96 %) |
Mar 08 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.52 | 25,550 | 217,775 | 1,813,609 | 1.8 M to 1.8 M (-1.39 %) |
Mar 08 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.80 | 17,500 | 154,011 | 1,796,109 | 1.8 M to 1.8 M (-0.96 %) |
Mar 08 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.52 | 25,550 | 217,775 | 1,813,609 | 1.8 M to 1.8 M (-1.39 %) |
Mar 01 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.36 | 4,500 | 37,605 | 788,212 | 792.7 K to 788.2 K (-0.57 %) |
Mar 01 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.36 | 10,500 | 87,745 | 1,839,159 | 1.8 M to 1.8 M (-0.57 %) |
Mar 01 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.36 | 10,500 | 87,745 | 1,839,159 | 1.8 M to 1.8 M (-0.57 %) |
Feb 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.09 | 14,000 | 113,225 | 1,849,659 | 1.9 M to 1.8 M (-0.75 %) |
Feb 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.01 | 7,000 | 56,041 | 1,863,659 | 1.9 M to 1.9 M (-0.37 %) |
Feb 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.10 | 343 | 2,778 | 1,870,659 | 1.9 M to 1.9 M (-0.02 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 7.43 | 81,185 | 603,205 | 81,185 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 6.77 | 116,046 | 785,631 | 116,046 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 7.43 | 12,415 | 92,243 | 12,415 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 6.77 | 14,154 | 95,823 | 14,154 |